DK0530639T3 - Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere - Google Patents

Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere

Info

Publication number
DK0530639T3
DK0530639T3 DK92114428.3T DK92114428T DK0530639T3 DK 0530639 T3 DK0530639 T3 DK 0530639T3 DK 92114428 T DK92114428 T DK 92114428T DK 0530639 T3 DK0530639 T3 DK 0530639T3
Authority
DK
Denmark
Prior art keywords
phenylacetamides
lipoxygenase inhibitors
heterocyclic substituted
quinolylmethoxy
substituted quinolylmethoxy
Prior art date
Application number
DK92114428.3T
Other languages
Danish (da)
English (en)
Inventor
Siegfried Dr Raddatz
Reiner Pro Mueller-Peddinghaus
Michael Dr Matzke
Armin Dr Hatzelmann
Klaus-Helmut Mohrs
Romanis Fruchtmann
Christian Dr Kohlsdorfer
Dr Theisen-Popp
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0530639T3 publication Critical patent/DK0530639T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92114428.3T 1991-09-06 1992-08-25 Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere DK0530639T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4129742A DE4129742A1 (de) 1991-09-06 1991-09-06 Heterocyclisch substituierte chinolylmethoxy-phenylacetamide

Publications (1)

Publication Number Publication Date
DK0530639T3 true DK0530639T3 (da) 1994-12-05

Family

ID=6440067

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92114428.3T DK0530639T3 (da) 1991-09-06 1992-08-25 Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere

Country Status (19)

Country Link
US (1) US5266578A (hu)
EP (1) EP0530639B1 (hu)
JP (1) JPH05194403A (hu)
KR (1) KR930006004A (hu)
CN (1) CN1070190A (hu)
AT (1) ATE110070T1 (hu)
AU (1) AU649351B2 (hu)
CA (1) CA2077465A1 (hu)
CZ (1) CZ276092A3 (hu)
DE (2) DE4129742A1 (hu)
DK (1) DK0530639T3 (hu)
ES (1) ES2057953T3 (hu)
FI (1) FI923968A (hu)
HU (1) HUT65660A (hu)
IL (1) IL103040A0 (hu)
MX (1) MX9204913A (hu)
NO (1) NO923181L (hu)
NZ (1) NZ244225A (hu)
TW (1) TW221431B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4219765A1 (de) * 1992-06-17 1993-12-23 Bayer Ag Substituierte (Benzothiazolyl- und Chinoxalyl-methoxy)phenylessigsäurederivate
ES2062943B1 (es) * 1993-03-23 1995-11-16 Uriach & Cia Sa J Nuevos derivados de la (2-metil-3-piridil) cianometilpiperazinas.
EP0634169B1 (en) * 1993-06-29 2000-01-05 Takeda Chemical Industries, Ltd. Quinoline or quinazoline derivatives and their use in the manufacture of a medicament for the treatment of osteoporosis
ES2103180B1 (es) * 1994-08-01 1998-04-01 Menarini Lab Fenilacetamidas con accion antagonista de los leucotrienos.
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
EP0725063A1 (de) * 1995-02-01 1996-08-07 Ciba-Geigy Ag Chinolin-Derivate
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6399641B1 (en) * 2000-07-13 2002-06-04 Hoffmann-La Roche Inc. 2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists
MXPA06002567A (es) * 2003-09-06 2006-09-04 Vertex Pharma Moduladores de transportadores con casete de union de atp.
KR102393675B1 (ko) * 2021-08-20 2022-05-11 (주)삼우공간건축사사무소 공동주택용 세대현관의 안전바닥패널

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU612569B2 (en) * 1986-03-13 1991-07-18 Rorer International (Overseas) Inc. Quinolinyl ether or thioether tetrazoles as agents for the treatment of hypersensitive ailments
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
US5102881A (en) * 1988-06-27 1992-04-07 Merck Frosst Canada, Inc. Quinoline ether alkanoic acids
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5041453A (en) * 1990-05-30 1991-08-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Quinolinyl-benzoheterobicyclic derivatives as antagonists of leukotriene D4

Also Published As

Publication number Publication date
CA2077465A1 (en) 1993-03-07
ATE110070T1 (de) 1994-09-15
JPH05194403A (ja) 1993-08-03
AU2205492A (en) 1993-03-11
NZ244225A (en) 1994-08-26
EP0530639A1 (de) 1993-03-10
FI923968A0 (fi) 1992-09-04
DE59200387D1 (de) 1994-09-22
ES2057953T3 (es) 1994-10-16
MX9204913A (es) 1993-03-01
CN1070190A (zh) 1993-03-24
AU649351B2 (en) 1994-05-19
CZ276092A3 (en) 1993-06-16
KR930006004A (ko) 1993-04-20
HU9202850D0 (en) 1992-11-30
HUT65660A (en) 1994-07-28
FI923968A (fi) 1993-03-07
IL103040A0 (en) 1993-02-21
US5266578A (en) 1993-11-30
NO923181L (no) 1993-03-08
NO923181D0 (no) 1992-08-14
DE4129742A1 (de) 1993-03-11
EP0530639B1 (de) 1994-08-17
TW221431B (hu) 1994-03-01

Similar Documents

Publication Publication Date Title
EA200100772A1 (ru) Бензогетероциклы и их применение в качестве мек ингибиторов
FI893433A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
DE69300043D1 (de) Substituierte Pipecoline-Säurederivate als HIV-Protease-Hemmer.
DK0563345T3 (da) Nye 4-arylpiperaziner og 4-arylpiperidiner
NO20005237L (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
DK1273299T3 (da) Minoxidilinindeholdende praparater
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
EA200100921A1 (ru) Диамиды пиридин-2,3-дикарбоновой кислоты
PT1023267E (pt) Compostos de piridilo e composicoes farmaceuticas que os contem
NO940144L (no) 2-(4-hydroksypiperidino)1-alkanolderivater som antiiskemiske midler
DK0530639T3 (da) Heterocyclisk substituerede quinolylmethoxy-phenylacetamider som lipoxygenasehæmmere
DE69104615D1 (de) Diphenylpiperazinderivat.
DE69902526D1 (de) Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate
ATE164159T1 (de) Substituierte triole
NO940523L (no) Nye pyrazin-derivater
ES2167931T3 (es) Derivados bifenilicos sustituidos por un radical aromatico o heteroaromatico y composiciones farmaceuticas y cosmeticas que los contienen.
NO962717D0 (no) Diaryl-5,6-kondenserte, heterosykliske syrer som leukotrienantagonister
ATE259813T1 (de) Triazolopyrimidinderivate
EA199800675A1 (ru) Дифенилстильбены как пролекарства к ингибиторам циклооксигеназы(сох-2)
ATE160146T1 (de) Hetero-tricyclisch-substituierte phenyl- cyclohexan-carbonsäurederivate
FI960371A (fi) Tiatsolijohdannaisia lipoksigenaasi-inhibiittoreina
FR2426685A2 (fr) Derives d'acides thiazolidinecarboxyliques et d'acides apparentes, utiles comme agents anti-hypertension
EA200200321A1 (ru) Апоптин-ассоциированный белок
NO950212L (no) Indolinyl-N-hydroksyurinstoff- og -N-hydroksamsyrederivater som lipoksygenase-inhibitorer